Immunic, Inc.
IMUX
$1.12
-$0.03-2.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.18M | -24.37M | -21.38M | -29.58M | -21.57M |
| Total Depreciation and Amortization | 35.00K | 42.00K | 31.00K | 26.00K | 23.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.11M | 1.97M | 1.40M | 9.58M | 1.45M |
| Change in Net Operating Assets | 71.00K | 1.56M | 2.92M | -3.99M | 6.07M |
| Cash from Operations | -22.96M | -20.80M | -17.03M | -23.97M | -14.03M |
| Capital Expenditure | -3.00K | -50.00K | -180.00K | -31.00K | -165.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -3.00K | -50.00K | -180.00K | -31.00K | -165.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 74.27M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 83.00K | 0.00 | 0.00 | 191.00K | 604.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -- | -- | -- | -- |
| Cash from Financing | 77.00K | 0.00 | 0.00 | 74.46M | 604.00K |
| Foreign Exchange rate Adjustments | -514.00K | 226.00K | -403.00K | 174.00K | 573.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.40M | -20.63M | -17.61M | 50.64M | -13.02M |